Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)
ArchivedNational Institutes of Health
Description
The purpose of this FOA is encourage and support the development of effective strategies for expanding the provision of HIV pre-exposure prophylaxis (PrEP) in sexually transmitted infection (STI) service settings in high priority jurisdictions identified by the presidential initiative, Ending the HIV Epidemic: A Plan for America. Funding for the fourth and fifth years (s) will be dependent upon achieving negotiated go/no go criteria and milestones.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>grantsinfo@nih.gov
grantsinfo@nih.gov
- PostedJun 15, 2021
- ClosesOct 13, 2021
- CFDA93.242, 93.279, 93.855
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro